Background: The implications of removing nonrestorative sleep (NRS) and adding quantitative criteria in the most recent diagnostic criteria of insomnia disorder remain unresolved. The study was aimed to investigate how nighttime quantitative measures of sleep quality and NRS relate to daytime functioning in a general population sample. Sampling and Methods: Data of 905 subjects (mean age = 47.0 years; 64.5% females) in a population-based survey who had insomnia symptoms or NRS at least 1 night in a typical week were analyzed to evaluate their relationship with “functional impairment,” “concerns/distress,” and “interference with daily activities” over the past 30 days. Receiver-operating characteristic curve analysis was performed, while controlling for age and gender. Results: Moderate to severe NRS was the first-level predictor of all 3 daytime variables. Insomnia frequency ≥3 times per week and sleep onset latency ≥10–20 min were second-level predictors. Conclusions: We found that NRS was more important than insomnia symptoms in determining daytime consequences of insomnia. On the basis of our findings we express concerns whether the removal of NRS from the most recent diagnostic criteria may lead to its underrecognition, but support the quantitative criteria on insomnia frequency of at least 3 nights per week.

1.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, American Psychiatric Association Publishing, 2014.
2.
American Academy of Sleep Medicine: The International Classification of Sleep Disorders, ed 3. Westchester, American Academy of Sleep Medicine, 2014.
3.
Cheung JM, Bartlett DJ, Armour CL, Glozier N, Saini B: Insomnia patients’ help-seeking experiences. Behav Sleep Med 2014; 12: 106–122.
4.
Fortier-Brochu É, Beaulieu-Bonneau S, Ivers H, Morin CM: Relations between sleep, fatigue, and health-related quality of life in individuals with insomnia. J Psychosom Res 2010; 69: 475–483.
5.
Morin CM, LeBlanc M, Daley M, Gregoire JP, Mérette C: Epidemiology of insomnia: prev-alence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 2006; 7: 123–130.
6.
Riedel BW, Lichstein KL: Insomnia and daytime functioning. Sleep Med 2000; 4: 277–298.
7.
Drake CL, Vargas I, Roth T, Friedman NP: Quantitative measures of nocturnal insomnia symptoms predict greater deficits across multiple daytime impairment domains. Behav Sleep Med 2015; 13: 73–87.
8.
Ohayon MM, Riemann D, Morin C, Reynolds CF: Hierarchy of insomnia criteria based on daytime consequences. Sleep Med 2012; 13: 52–57.
9.
Ustinov Y, Lichstein KL, Wal GSV, Taylor DJ, Riedel BW, Bush AJ: Association between report of insomnia and daytime functioning. Sleep Med 2010; 11: 65–68.
10.
Stone KC, Taylor DJ, McCrae CS, Kalsekar A, Lichstein KL: Nonrestorative sleep. Sleep Med Rev 2008; 12: 275–288.
11.
Ohayon MM: Prevalence and correlates of nonrestorative sleep complaint. Arch Intern Med 2005; 165: 35–41.
12.
Roth T, Zammit G, Lankford A, Mayleben D, Stern T, Pitman V, Clark D, Werth JL: Nonrestorative sleep as a distinct component of insomnia. Sleep 2010; 33: 449–458.
13.
Sarsour K, Van Brunt DL, Johnston JA, Foley KA, Morin CM, Walsh JK: Associations of nonrestorative sleep with insomnia, depression, and daytime function. Sleep Med 2010; 11: 965–972.
14.
Foley KA, Sarsour K, Kalsekar A, Walsh JK: Subtypes of sleep disturbance: associations among symptoms, comorbidities, treatment, and medical costs. Behav Sleep Med 2010; 8: 90–104.
15.
Chung KF, Yeung WF, Ho FY, Yung KP, Yu YM, Kwok CW: Cross-cultural and comparative epidemiology of insomnia: the diagnostic and statistical manual (DSM), international classification of diseases (ICD) and international classification of sleep disorders (ICSD). Sleep Med 2015; 16: 477–482.
16.
Chung KF, Yeung WF, Ho FY, Ho LM, Yung KP, Yu Y, Kwok CW: Validity and reliability of the brief insomnia questionnaire in the general population in Hong Kong. J Psychosom Res 2014; 76: 374–379.
17.
Chung KF, Yeung WF, Ho FY, Ho LM, Yung KP, Yu YM, Kwok CW: Comparison of scoring methods for the brief insomnia questionnaire in a general population sample. J Psychosom Res 2015; 78: 34–38.
18.
Kessler RC, Coulouvrat C, Hajak G, Lakoma MD, Roth T, Sampson N, Shahly V, Shillington A, Stephenson JJ, Walsh JK, Zammit GK: Reliability and validity of the brief insomnia questionnaire in the America insomnia survey. Sleep 2010; 33: 1539–1549.
19.
Okamoto MM, Kobayashi Y, Nakamura F, Musha T: Association between nonrestorative sleep and risk of diabetes: a cross-sectional study. Behav Sleep Med 2017; 15: 483–490.
20.
Zhang J, Lam SP, Li SX, Li AM, Wing YK: The longitudinal course and impact of non-restorative sleep: a five-year community-based follow-up study. Sleep Med 2012; 13: 570–576.
21.
Zhang J, Lamers F, Hickie IB, He J, Feig E, Merikangas KR: Differentiating nonrestorative sleep from nocturnal insomnia symptoms: demographic, clinical, inflammatory, and functional correlates. Sleep 2013; 36: 671–679.
22.
Léger D, Partinen M, Hirshkowitz M, Chokroverty S, Hedner J: Characteristics of insomnia in a primary care setting: EQUINOX survey of 5,293 insomniacs from 10 countries. Sleep Med 2010; 11: 987–998.
23.
Drake CL, Hays RD, Morlock R, Wang F, Shikiar R, Frank L, Downey R, Roth T: Development and evaluation of a measure to assess restorative sleep. J Clin Sleep Med 2014; 10: 733–741.
24.
Wilkinson K, Shapiro C: Development and validation of the nonrestorative sleep scale (NRSS). J Clin Sleep Med 2013; 9: 929–937.
25.
Lineberger MD, Carney CE, Edinger JD, Means MK: Defining insomnia: quantitative criteria for insomnia severity and frequency. Sleep 2006; 29: 479–485.
26.
Natale V, Léger D, Bayon V, Erbacci A, To netti L, Fabbri M, Martoni M: The consensus sleep diary: quantitative criteria for primary insomnia diagnosis. Psychosom Med 2015; 77: 413–418.
27.
Lichstein KL, Durrence HH, Taylor DJ, Bush AJ, Riedel BW: Quantitative criteria for insomnia. Behav Res Ther 2003; 41: 427–445.
28.
Tutek J, Emert SE, Dautovich ND, Lichstein KL: Association between chronotype and nonrestorative sleep in a college population. Chronobiol Int 2016; 33: 1293–1304.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.